revamp – Health

A year into Sanofi’s revamp, CEO Paul Hudson collects €11.34M in 2020 pay—including that signing bonus

A few months after joining Sanofi in 2019, CEO Paul Hudson laid out new R&D priorities and cut bait on some operations that weren’t delivering. Then, several weeks later, he shook up management. That revamp began in December 2019. And for the first full year of his effort to revitalize the French drugmaker, the helmsman has collected a… Read More »

Sanofi, despite COVID-19, sees early gains from CEO Hudson’s strategy revamp

Less than a year ago, Sanofi’s CEO Paul Hudson unveiled the company’s new “play to win” strategy that centers the company on growth drivers such as Dupixent and vaccines. And that strategy delivered in the third quarter as Dupixent posted blockbuster sales and flu vaccines set a revenue record. First approved in March 2017, immunology med Dupixent delivered its first blockbuster quarter,… Read More »